Liver Cancer Trial, Recruiting NCT04365751 Sponsor: Chinese PLA General Hospital Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT04365751
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults over 18 years old, of any gender
  • People without liver scarring (cirrhosis) who have had liver cancer confirmed by a tissue biopsy within the past month before surgery, OR people with liver scarring whose liver cancer has been identified using a specialised MRI or CT scan showing characteristic patterns of the disease
  • People with no more than 3 tumours, where at least one tumour measures between 3.1 and 5.0 cm at its widest point
  • People whose cancer has not spread into blood vessels, lymph nodes, or other parts of the body
  • People whose liver is functioning at an acceptable level, based on a standard liver scoring system called Child-Pugh A or B, assessed within 14 days before surgery
  • People who understand the purpose of the study and are willing to sign a consent form to participate

Who may not be able to join:

  • People whose liver has stopped working properly, or who have had confusion related to liver failure, a large build-up of fluid in the abdomen, or bleeding from the digestive tract within the past month
  • People with blood clotting problems, including a platelet count below 50 x 10⁹/L or a blood clotting measurement (INR) above 1.5
  • People with serious heart, lung, or kidney problems
  • People who currently have an active infection
  • People who are pregnant
  • People with a history of substance abuse or mental illness
  • People whose body cannot tolerate the type of gas inflation used during keyhole (laparoscopic) surgery (confirm with trial site)
  • People who have taken part in another clinical study or received anti-cancer treatment in the four weeks before joining this study
  • People whom the trial researchers consider unsuitable for any other reason that could affect safe participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ping Liang, Doctor, Chinese PLA General Hospital

Phone: 8601066939530

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chinese PLA General Hospital
Registry
ClinicalTrials.gov
Start date
26 December 2019
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov